X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs TORRENT PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD TORRENT PHARMA WYETH LTD/
TORRENT PHARMA
 
P/E (TTM) x 27.7 28.6 96.8% View Chart
P/BV x 5.3 5.4 98.2% View Chart
Dividend Yield % 1.3 1.0 127.3%  

Financials

 WYETH LTD   TORRENT PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
TORRENT PHARMA
Mar-17
WYETH LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,768 59.1%   
Low Rs8181,186 69.0%   
Sales per share (Unadj.) Rs298.6346.1 86.3%  
Earnings per share (Unadj.) Rs57.255.2 103.8%  
Cash flow per share (Unadj.) Rs58.473.3 79.7%  
Dividends per share (Unadj.) Rs17.0014.00 121.4%  
Dividend yield (eoy) %1.80.9 192.6%  
Book value per share (Unadj.) Rs249.5257.1 97.0%  
Shares outstanding (eoy) m22.72169.22 13.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.3 73.1%   
Avg P/E ratio x16.326.8 60.8%  
P/CF ratio (eoy) x15.920.1 79.1%  
Price / Book Value ratio x3.75.7 65.0%  
Dividend payout %29.725.4 117.0%   
Avg Mkt Cap Rs m21,157249,887 8.5%   
No. of employees `0000.511.8 4.2%   
Total wages/salary Rs m4009,934 4.0%   
Avg. sales/employee Rs Th13,787.44,971.5 277.3%   
Avg. wages/employee Rs Th813.0843.2 96.4%   
Avg. net profit/employee Rs Th2,643.3792.4 333.6%   
INCOME DATA
Net Sales Rs m6,78358,569 11.6%  
Other income Rs m3532,233 15.8%   
Total revenues Rs m7,13660,802 11.7%   
Gross profit Rs m1,61713,773 11.7%  
Depreciation Rs m273,069 0.9%   
Interest Rs m62,056 0.3%   
Profit before tax Rs m1,93810,881 17.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,545 40.9%   
Profit after tax Rs m1,3019,336 13.9%  
Gross profit margin %23.823.5 101.4%  
Effective tax rate %32.614.2 229.7%   
Net profit margin %19.215.9 120.3%  
BALANCE SHEET DATA
Current assets Rs m6,98453,841 13.0%   
Current liabilities Rs m2,05631,612 6.5%   
Net working cap to sales %72.638.0 191.4%  
Current ratio x3.41.7 199.4%  
Inventory Days Days9997 102.1%  
Debtors Days Days2484 28.6%  
Net fixed assets Rs m24442,079 0.6%   
Share capital Rs m227846 26.8%   
"Free" reserves Rs m5,44142,655 12.8%   
Net worth Rs m5,66843,501 13.0%   
Long term debt Rs m2522,408 0.1%   
Total assets Rs m7,901101,250 7.8%  
Interest coverage x353.36.3 5,614.3%   
Debt to equity ratio x00.5 0.9%  
Sales to assets ratio x0.90.6 148.4%   
Return on assets %16.511.3 146.9%  
Return on equity %22.921.5 106.9%  
Return on capital %34.019.6 173.5%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1520,066 0.1%   
Fx outflow Rs m2,6775,304 50.5%   
Net fx Rs m-2,66214,762 -18.0%   
CASH FLOW
From Operations Rs m92310,127 9.1%  
From Investments Rs m317-7,869 -4.0%  
From Financial Activity Rs m-481-1,918 25.1%  
Net Cashflow Rs m759212 358.9%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 7.0 161.0%  
FIIs % 7.2 12.6 57.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 8.8 345.5%  
Shareholders   21,978 26,511 82.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Red; Realty Stocks Top Losers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a dull note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - CIPLA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS